Synthesis of the C1-C12 fragment of the tedanolides.  Aldol-non-aldol aldol approach. 
The combination of highly stereoselective non-aldol aldol and aldol processes allows the preparation of the completely protected C1-C12 fragment 2 of the novel macrocyclic cytotoxic agent tedanolide 1.